United States· US:85037-002_397a7584-1d37-d155-e063-6294a90a08f6
Sungboon Editor Daily Invisible Blurring Sunscreen
A medicinal product containing avobenzone, homosalate, octisalate, octocrylene, registered in United States by Olive International Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Avobenzone, Homosalate, Octisalate, Octocrylene
- Manufacturer
- Olive International Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1185037002021 TUBE in 1 CARTON (85037-002-02) / 50 mL in 1 TUBE (85037-002-01)
Regulatory notes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc379e52-508b-40dd-a57c-e0e2a19a7143 GET /v1/drugs/bc379e52-508b-40dd-a57c-e0e2a19a7143?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "G63QQF2NOX",
"rxcui": "45045",
"inchikey": "XNEFYCZVKIDDMS-UHFFFAOYSA-N",
"display_name": "AVOBENZONE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "TOPICAL",
"spl_meta": {
"42325963-0917-43c4-8fe0-130336c7fa81": {
"match": "brand_token",
"title": "SUNGBOON EDITOR DAILY INVISIBLE BLURRING SUNSCREEN (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) CREAM [OLIVE INTERNATIONAL INC.]",
"spl_version": "3",
"published_date": "2025-07-10"
}
},
"productid": "85037-002_397a7584-1d37-d155-e063-6294a90a08f6",
"productndc": "85037-002",
"dosage_form": "CREAM",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE",
"proprietary_name": "Sungboon Editor Daily Invisible Blurring Sunscreen",
"active_ingred_unit": "mg/mL; mg/mL; mg/mL; mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG",
"nonproprietary_name": "Avobenzone, Homosalate, Octisalate, Octocrylene",
"start_marketing_date": "20250325",
"active_numerator_strength": "29; 100; 49; 90"
}See everything about avobenzone, homosalate, octisalate, octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.